Showing results (281-290 of 447) with videos related to
Sort By:
Pageof 45
European Heart Journal|March 15, 2013
Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantationPeter Wenaweser, Stefan Stortecky, Sarah Schwander, et al.JACC. Cardiovascular Interventions|January 26, 2013
Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacementLutz Buellesfeld, Stefan Stortecky, Bindu Kalesan, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2011
Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantationPeter Wenaweser, Thomas Pilgrim, Enio Guerios, et al.International Journal of Cardiology|September 3, 2013
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trialsAntoinette de Waha, Giulio G Stefanini, Lamin A King, et al.International Journal of Cardiology|June 4, 2017
Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trialDiego Arroyo, Gregoire Gendre, Sara Schukraft, et al.European Heart Journal. Cardiovascular Imaging|April 25, 2013
Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejectionTobias Rutz, Stefano F de Marchi, Patrizia Roelli, et al.American Heart Journal|September 1, 2014
Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trialThomas Pilgrim, Marco Roffi, David Tüller, et al.Trials|January 9, 2014
Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trialDiego Arroyo, Mario Togni, Serban Puricel, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 25, 2020
Randomized Comparison of Optical Coherence Tomography Versus Angiography to Guide Bioresorbable Vascular Scaffold Implantation: The OPTICO BVS StudyYasushi Ueki, Kyohei Yamaji, Emanuele Barbato, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 26, 2021
Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffoldsSara Schukraft, Diego Arroyo, Mario Togni, et al.Pageof 45